LMR Partners’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

LMR Partners’s Portfolio CRXTW Stock Details CRXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-229,750	Closed	-$88K	–	1363
2022 Q2	$88K	Hold	229,750	–	–	﹤0.01%	1110
2022 Q1	$342K	Hold	229,750	–	–	﹤0.01%	1052
2021 Q4	$558K	Hold	229,750	–	–	0.01%	867
2021 Q3	$1.23M	Buy	+229,750	New	+$173K	0.01%	581

Other funds holding CRXTW

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

LMR Partners's CRXTW Position: Q3 2022 in Review

LMR Partners sold out of Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) in Q3 2022, closing a stake of 229,750 shares — an estimated $88K sold.

LMR Partners first reported a position in CRXTW in Q3 2021 and held it in 4 quarters. The position peaked at $1.23M in Q3 2021. 5 funds tracked by Wall St. Rank hold CRXTW as of Q3 2022.

LMR Partners reported no remaining Clarus Therapeutics Holdings, Inc. Warrants position as of Q3 2022 after selling out during the quarter.
LMR Partners sold 229,750 Clarus Therapeutics Holdings, Inc. Warrants shares in Q3 2022, an estimated $88K.
LMR Partners first reported a position in Clarus Therapeutics Holdings, Inc. Warrants in Q3 2021 and held it in 4 quarters.
LMR Partners's Clarus Therapeutics Holdings, Inc. Warrants position peaked at $1.23M in Q3 2021.
5 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Warrants as of Q3 2022.

Based on LMR Partners's 13F filing for Q3 2022, filed 14 Nov 2022.